BE study design question [Design Issues]

posted by jag009  – NJ, 2012-04-18 17:21 (5177 d 09:11 ago) – Posting: # 8441
Views: 2,685

❝ Hi John,


❝ I think an SD study for swallowed dosing will suffice. For example, the FDA's product-specific guidance for montelukast chewable tablets (http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm088707.pdf) states that the tablet should be swallowed whole - this would ensure the standardised delivery of the dose, as opposed to variability introduced during chewing.

.
.

Thanks Clare

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
129 visitors (0 registered, 129 guests [including 29 identified bots]).
Forum time: 02:33 CEST (Europe/Vienna)

Scientists cannot simply hang their subjectivities
up on a hook outside the laboratory door.    Ruth Bleier

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5